ROS1 and non-small cell lung carcinoma: A meta‐analysis of 9898 patients with NSCLC indicated that ROS1 fusion occurred in younger female patients with no smoking history and was more prevalent in patients with advanced disease (stage III–IV) than those with early disease (p < 0.001).47